TIS 0.00% 0.0¢ tissue therapies limited

late again.... no news at all, page-3

  1. 1,083 Posts.
    lightbulb Created with Sketch. 1515
    No news on the trials is actually good news. We would have heard by now if it had gone off the rails. A few more weeks is not unreasonable to analyse the results, write the report, review it and approve it, and publish it.

    As for a partner deal, TIS is better off not giving a target date as that would (again) put it in a weaker bargaining position leading up to any target date.

    Patience all, it should be a great year.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.